Wednesday, 12 Dec 2018

You are here

Predictive Risk Factors for Uveitis in JIA

Researchers from Germany have studied a large cohort of juvenile idiopathic arthritis (JIA) patients and shown that JIA disease activity scores and laboratory biomarkers could be used to better define the group of JIA patients at high risk of uveitis onset.

They studied 964 JIA kids enrolled within the first year of their JIA diagnosis. Of these, two-thirds were female, 54.2% were antinuclear antibody [ANA] positive, and their mean age at onset was 7.1 years.

Uveitis occurred in 133 patients (13.7%).  Predictors of uveitis included younger age at onset and ANA positivity (P < 0.001). 

Prevention of uveitis was observed with methotrexate (hazard ratio [HR] 0.18 [95% confidence interval (95% CI) 0.12–0.29], P < 0.001), etanercept (HR 0.10; 0.04–0.23) or adalimumab (HR 0.09; 0.01–0.61).

Other significant lab and biomarker predictors of uveitis included an elevated erythrocyte sedimentation rate at baseline (HR 2.36), moderate or high disease activity during (HR 4.30), and S100A12 levels ≥250 ng/ml at baseline (HR 2.10).

Uveitis may be a serious vision‐threatening complication of JIA and these data may bolster future prevention strategies in newly diagnosed JIA.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

CV Risks Similar in Systemic Sclerosis and Rheumatoid Arthritis

Interactions between disease-related inflammatory processes and the development of several morbidities have been well-studied in RA, particularly heart disease. This is not the case for the often-lethal SSc (estimated standardized mortality ratio between 2.5 and 4.0). Similarly, there are no studies comparing the most relevant comorbidities between SSc and RA.

PRAIRI Study - Can RA Be Prevented?

B-cell depletion may offer a means of delaying the onset of clinical arthritis in adults at high risk, according to the PRAIRI study - a proof-of-mechanism study in pre-clinical RA patients. 

Rheumatoid Lung Disease Imposes Significant Morbidity and Mortality

Insurance claims data were analyzed for the frequency of interstitial lung disease (ILD) associated with rheumatoid arthritis (RA) and finds that although rare, its frequency increased over time and it is associated with a significant mortality rate. 

The study was done because RA-ILD has been shown to cause significant morbidity and mortality. 

Growing Tick Population Comes with Health Concerns

CNN has published a recent government report from the Tick-Borne Disease Working Group that suggests the US tick population is growing and may bring with it an increase in tick-related illnesses. 

While Lyme disease is the most popular of tick-borne illnesses, there are another 20 known conditions related to tick bites.

Chikungunya Virus Vaccine Developed

Lancet reports on a new vaccine for Chikungunya fever (MV-CHIK) demonstraing excellent safety, tolerability and good immunogenicity, independent of pre-existing immunity against the vector. MV-CHIK is a promising vaccine for the prevention of chikungunya fever.